Based on the current political developments in Europe and the formulation of a National Strategy for Rare Diseases there is a need to provide suitable therapeutic options to underserved populations such as paediatric population and people living with rare diseases....
Interview with the expert – ATMPs as Therapy Options in Europe
read more